- Home
- MG vs LRMR Comparison
MG vs LRMR Comparison
Compare MG & LRMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MG
- LRMR
- Stock Information
- Founded
- MG 1978
- LRMR N/A
- Country
- MG United States
- LRMR United States
- Employees
- MG N/A
- LRMR N/A
- Industry
- MG Military/Government/Technical
- LRMR Biotechnology: Pharmaceutical Preparations
- Sector
- MG Consumer Discretionary
- LRMR Health Care
- Exchange
- MG Nasdaq
- LRMR Nasdaq
- Market Cap
- MG 366.2M
- LRMR 426.9M
- IPO Year
- MG 2009
- LRMR N/A
- Fundamental
- Price
- MG $9.15
- LRMR $6.13
- Analyst Decision
- MG Hold
- LRMR Strong Buy
- Analyst Count
- MG 1
- LRMR 8
- Target Price
- MG $11.00
- LRMR $19.63
- AVG Volume (30 Days)
- MG 182.5K
- LRMR 755.1K
- Earning Date
- MG 10-30-2024
- LRMR 10-30-2024
- Dividend Yield
- MG N/A
- LRMR N/A
- EPS Growth
- MG N/A
- LRMR N/A
- EPS
- MG 0.36
- LRMR N/A
- Revenue
- MG $738,983,000.00
- LRMR N/A
- Revenue This Year
- MG $6.49
- LRMR N/A
- Revenue Next Year
- MG $2.75
- LRMR N/A
- P/E Ratio
- MG $26.05
- LRMR N/A
- Revenue Growth
- MG 6.85
- LRMR N/A
- 52 Week Low
- MG $6.30
- LRMR $3.19
- 52 Week High
- MG $12.44
- LRMR $13.68
- Technical
- Relative Strength Index (RSI)
- MG 41.76
- LRMR 36.77
- Support Level
- MG $8.67
- LRMR $5.92
- Resistance Level
- MG $9.14
- LRMR $6.60
- Average True Range (ATR)
- MG 0.34
- LRMR 0.70
- MACD
- MG 0.04
- LRMR -0.30
- Stochastic Oscillator
- MG 64.49
- LRMR 11.78
About MG Mistras Group Inc
MISTRAS Group Inc provides asset protection solutions and systems. The company evaluates the structural integrity and reliability of critical energy, industrial, and public infrastructure. The company's three operating segments are North America, International and Products and Systems, of which key revenue is derived from the North America segment. Services segment provides asset protection solutions predominantly in North America, with the large amount of concentration in the United States, followed by Canada, consisting of non-destructive testing, and inspection. The asset protection solutions include field inspections, consulting, maintenance, data management, access, monitoring and laboratory quality assurance.
About LRMR Larimar Therapeutics Inc.
Larimar Therapeutics Inc is a clinical-stage biotechnology company focused on developing treatments for patients suffering from complex rare diseases using novel cell-penetrating peptide technology platform. Its lead product candidate, CTI-1601, is a subcutaneously administered, recombinant fusion protein intended to deliver human frataxin (FXN) an essential protein, to the mitochondria of patients with Friedreich's ataxia.